Log In
Print this Print this

Seebri Breezhaler, glycopyrronium bromide (NVA237) (formerly AD 237)

Also known as: Enurev Breezhaler, Tovanor Breezhaler

  Manage Alerts
Collapse Summary General Information
Company Sosei Group Corp.
DescriptionInhaled long-acting muscarinic receptor antagonist (LAMA)
Molecular Target Muscarinic receptor
Mechanism of ActionMuscarinic receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationChronic obstructive pulmonary disease (COPD)
Indication DetailsTreat chronic obstructive pulmonary disease (COPD)
Regulatory Designation


Novartis AG; Pfizer Inc.; Vectura Group plc

 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today